Breast cancer therapy affects the expression of antineonatal Nav1.5 antibodies in the serum of patients with breast cancer

Neonatal Nav1.5 (nNav1.5) is the alternative splice variant of Nav1.5 and it has been widely associated with the progression of breast cancer. The immunological context of nNav1.5 with respect to breast cancer metastases remains unexplored. The presence of antibodies against nNav1.5 may highlight th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajaratinam, Harishini, Rasudin, Nur Syahmina, Al Astani, Tengku Ahmad Damitri, Mokhtar, Noor Fatmawati, Yahya, Maya Mazuwin, Wan Zain, Wan Zainira, Asma-Abdullah, Nurul, Mohd Fuad, Wan Ezumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751336/
https://www.ncbi.nlm.nih.gov/pubmed/33376541
http://dx.doi.org/10.3892/ol.2020.12369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751336/
https://www.ncbi.nlm.nih.gov/pubmed/33376541
http://dx.doi.org/10.3892/ol.2020.12369

Ejemplares similares